These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. The inherent invasiveness of cerebral gliomas: implications for clinical management. Laws ER; Shaffrey ME Int J Dev Neurosci; 1999; 17(5-6):413-20. PubMed ID: 10571404 [No Abstract] [Full Text] [Related]
44. Aggressive and invasive growth of tectal glioma after surgical intervention and chemoradiotherapy. Matsuno A; Nagashima H; Ishii H; Iwamuro H; Nagashima T Br J Neurosurg; 2006 Aug; 20(4):246-9. PubMed ID: 16954079 [TBL] [Abstract][Full Text] [Related]
45. Phase I trial of panobinostat and fractionated stereotactic re-irradiation therapy for recurrent high grade gliomas. Shi W; Palmer JD; Werner-Wasik M; Andrews DW; Evans JJ; Glass J; Kim L; Bar-Ad V; Judy K; Farrell C; Simone N; Liu H; Dicker AP; Lawrence YR J Neurooncol; 2016 May; 127(3):535-9. PubMed ID: 26821711 [TBL] [Abstract][Full Text] [Related]
46. Farewell to monomodality treatment in patients with WHO lower grade glioma? Le Rhun E; Gorlia T Eur J Cancer; 2018 Jan; 88():109-114. PubMed ID: 29239741 [No Abstract] [Full Text] [Related]